Skip to main content
CMG Pharmaceutical Co., Ltd. logo

CMG Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 058820 ISIN · KR7058820002 KO Manufacturing
Open in API
Filings indexed 165 across all filing types
Latest filing 2020-03-12 Proxy Solicitation & In…
Country KR South Korea
Listing KO 058820

About CMG Pharmaceutical Co., Ltd.

http://www.cmgpharma.co.kr

CMG Pharmaceutical Co., Ltd. is a pharmaceutical company specializing in the development of advanced drug delivery systems. The company's core competency is its Oral Thin Film (OTF), or Orally Dissolving Film (ODF), technology platform. This technology is used to develop improved new drugs, new formulations, and combination therapies designed to enhance patient convenience and efficacy. The company's portfolio includes prescription medications and general pharmaceuticals. As an affiliate of CHA Health Systems, CMG Pharmaceutical is actively engaged in research and development, managing a pipeline of drug candidates and conducting clinical trials.

Recent filings

Filing Released Lang Actions
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a 'Reference Document' (참고서류) filed by CMG Pharmaceutical Co., Ltd. in preparation for its 19th Annual General Meeting (AGM) scheduled for March 27, 2020. It contains proxy solicitation information, details about the solicitor, and agenda items including the approval of financial statements. This document is a standard proxy statement/information circular provided to shareholders to facilitate voting at the AGM. In the context of the provided categories, this fits best as a Proxy Solicitation & Information Statement (PSI).
2020-03-12 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for CMG Pharmaceutical. It outlines the date, location, and specific agenda items (approval of financial statements, election of directors and auditors, and remuneration limits). This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of upcoming voting matters, which falls under the Proxy Solicitation & Information Statement category.
2020-03-09 Korean
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal notification regarding the scheduling of a General Meeting of Shareholders on a 'concentrated day' (a date where many companies hold their meetings). It explains the rationale for choosing the specific date (March 27, 2020) based on audit report timelines and legal requirements. Since this is a regulatory notification regarding meeting logistics and scheduling rather than the meeting materials themselves or the voting results, it falls under the general regulatory filing category.
2020-03-09 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for CMG Pharmaceutical. It contains the meeting agenda, details on voting procedures (including electronic voting), and management information such as director activities and financial statements. This type of document is a standard proxy statement/notice of meeting sent to shareholders to inform them of the upcoming AGM and solicit their votes, which falls under the Proxy Solicitation & Information Statement category.
2020-03-09 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Proxy Solicitation' (위임권유신고서) filed by CMG Pharmaceutical Co., Ltd. It contains information regarding the solicitation of voting rights for the 19th Annual General Meeting of Shareholders, including the date, location, agenda items, and financial statements (balance sheet, income statement, etc.) to be approved. This document is a formal regulatory filing used to request shareholder proxies and provide necessary information for the upcoming meeting, which fits the definition of a Proxy Solicitation & Information Statement (PSI).
2020-03-09 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 95% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to employees, including the number of shares, exercise price, and valuation methodology. This type of disclosure regarding share-based compensation and capital structure changes falls under the category of share issues or capital changes.
2020-03-09 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.